NCT04073056View on ClinicalTrials.gov

Efficacy Of Quadratus Lumborum II Block For Laparoscopic Sleeve Gastrectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

February 23, 2021

Study Completion Date

February 23, 2021

Conditions
Morbid ObesityHigh BMI
Interventions
DRUG

Bupivacaine

Bupivacaine Hcl 0.25% Inj

Trial Locations (1)

10025

Mount Sinai St. Lukes Hospital, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT04073056 - Efficacy Of Quadratus Lumborum II Block For Laparoscopic Sleeve Gastrectomy | Biotech Hunter | Biotech Hunter